CALIXAR helps pharmaceutical and biotechnological companies as well as academic life sciences organizations to preserve and resolve the original structure of proteins during target discovery stage.
CALIXAR provides a range of services based on innovative technologies for production, extraction, solubilization, purification, stabilization and crystallization of functional membrane proteins / antigens.
We improve the reliability of targets for a better performance of high throughput screening and structure-based drug design approaches, the production of vaccines, biodrugs and for the development of diagnostic tools.
CALIXAR presents the Membrane Protein Alliance
The Membrane Protein Alliance, composed of CALIXAR and SYNTHELIS, is pleased to present its unique expertise in membrane protein. For a detailed presentation of the Membrane Protein Alliance and its global services, please view the video by clicking on the link hereafter: Presentation of the Membrane Protein Alliance